Denmark
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.77 B
|
Dec. 31, 2023 | USD 81.56 | -2.90% |
|
Denmark |
|
2 |
USD 4.68 B
|
Dec. 31, 2023 | USD 216.88 | 1.28% |
|
Denmark |
|
3 |
USD 3.26 B
|
Dec. 31, 2023 | USD 5.46 | 0.56% |
|
Denmark |
|
4 |
USD 2.68 B
|
Sept. 30, 2024 | USD 109.06 | -0.12% |
|
Denmark |
|
5 |
USD 2.07 B
|
Dec. 31, 2023 | USD 54.16 | -1.39% |
|
Denmark |
|
6 |
USD 1.53 B
|
Dec. 31, 2023 | USD 26.62 | -0.36% |
|
Denmark |
|
7 |
USD 834.79 M
|
Sept. 30, 2024 | USD 18.73 | 1.26% |
|
Denmark |
|
8 |
USD 658.24 M
|
Dec. 31, 2023 | USD 20.15 | -0.78% |
|
Denmark |
|
9 |
USD 235.77 M
|
Dec. 31, 2023 | USD 95.84 | 0.08% |
|
Denmark |
|
10 |
USD 81.40 M
|
June 30, 2024 | USD 70.50 | 0.61% |
|
Denmark |
|
11 |
USD 71.00 M
|
Dec. 31, 2023 | USD 91.43 | -1.85% |
|
Denmark |
|
12 |
USD 8.90 M
|
Dec. 31, 2023 | USD 0.20 | -2.77% |
|
Denmark |
|
13 |
USD 6.45 M
|
Dec. 31, 2023 | USD 2.17 | 5.88% |
|
Denmark |
|
14 |
USD -2.17 M
|
Dec. 31, 2023 | USD 0.57 | 1.47% |
|
Denmark |
|
15 |
USD -160.81 M
|
Dec. 31, 2023 | USD 131.57 | -1.84% |
|
Denmark |
The Pharmaceuticals company in Denmark with the highest Shareholders' Equity is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 15.77 B.
The Pharmaceuticals company in Denmark with the lowest Shareholders' Equity is Ascendis Pharma A/S (NasdaqGS: ASND) at USD -160.81 M.
The top 10 Pharmaceuticals companies in Denmark by Shareholders' Equity are Novo Nordisk A/S, Genmab A/S, H. Lundbeck A/S, Coloplast A/S, Novozymes A/S, Bavarian Nordic A/S, Ambu A/S, ALK-Abelló A/S, Zealand Pharma A/S and ChemoMetec A/S.
The bottom 10 Pharmaceuticals companies in Denmark by Shareholders' Equity are Ascendis Pharma A/S, Saniona AB (publ), ExpreS2ion Biotech Holding AB (publ), BioPorto A/S, Gubra A/S, ChemoMetec A/S, Zealand Pharma A/S, ALK-Abelló A/S, Ambu A/S and Bavarian Nordic A/S.